{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:11:22Z","timestamp":1793383882544,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00405-025-09508-4","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T14:39:10Z","timestamp":1749220750000},"page":"5635-5643","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of the effectiveness of bone obliteration in cholesteatoma surgery"],"prefix":"10.1007","volume":"282","author":[{"given":"J.","family":"Chomarat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schmerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3877-121X","authenticated-orcid":false,"given":"Rapha\u00eble","family":"Quatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"1","key":"9508_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5152\/iao.2017.3363","volume":"13","author":"M Yung","year":"2017","unstructured":"Yung M, Tono T, Olszewska E et al (2017) EAONO\/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma. J Int Adv Otol 13(1):1\u20138","journal-title":"J Int Adv Otol"},{"issue":"4","key":"9508_CR2","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/lary.25591","volume":"126","author":"KG Kerckhoffs","year":"2016","unstructured":"Kerckhoffs KG, Kommer MB, van Strien TH et al (2016) The disease recurrence rate after the Canal wall up or Canal wall down technique in adults. Laryngoscope 126(4):980\u2013987","journal-title":"Laryngoscope"},{"issue":"3","key":"9508_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000346140","volume":"18","author":"J Tomlin","year":"2013","unstructured":"Tomlin J, Chang D, McCutcheon B, Harris J (2013) Surgical technique and recurrence in cholesteatoma: a meta-analysis. Audiol Neurootol 18(3):135\u2013142","journal-title":"Audiol Neurootol"},{"issue":"5","key":"9508_CR4","first-page":"354","volume":"34","author":"SC Prasad","year":"2014","unstructured":"Prasad SC, La Melia C, Medina M et al (2014) Long-term surgical and functional outcomes of the intact Canal wall technique for middle ear cholesteatoma in the paediatric population. Acta Otorhinolaryngol Ital 34(5):354\u2013361","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"9508_CR5","unstructured":"Gjini EK, Kalmanson OA, Noonan K, Nassiri AM (2024) Techniques in management of cholesteatoma: radical and Canal wall down mastoidectomy. Otolaryngol Clin North Am. Published online September 10"},{"issue":"4","key":"9508_CR6","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/lio2.1096","volume":"8","author":"H Kara","year":"2023","unstructured":"Kara H, Sen C, Sonmez S, Celik M, Polat B (2023) The effect of bony obliteration on quality of life after tympano-mastoidectomy surgery: A prospective observational controlled cohort study. Laryngoscope Investig Otolaryngol 8(4):1052\u20131060","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"6","key":"9508_CR7","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00405-020-05881-4","volume":"277","author":"NM Weiss","year":"2020","unstructured":"Weiss NM, B\u00e4chinger D, Botzen J, Gro\u00dfmann W, Mlynski R (2020) Mastoid cavity obliteration leads to a clinically significant improvement in health-related quality of life. Eur Arch Otorhinolaryngol 277(6):1637\u20131643","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"9508_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1001\/jamaoto.2017.3401","volume":"144","author":"HFE Van der Toom","year":"2018","unstructured":"Van der Toom HFE, van der Schroeff MP, Pauw RJ (2018) Single-Stage mastoid obliteration in cholesteatoma surgery and recurrent and residual disease rates: A systematic review. JAMA Otolaryngol Head Neck Surg 144(5):440\u2013446","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"5","key":"9508_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/00016489.2017.1417634","volume":"138","author":"J Westerberg","year":"2018","unstructured":"Westerberg J, M\u00e4ki-Torkko E, Harder H (2018) Cholesteatoma surgery with the Canal wall up technique combined with mastoid obliteration: results from primary surgery in 230 consecutive cases. Acta Otolaryngol 138(5):452\u2013457","journal-title":"Acta Otolaryngol"},{"issue":"11","key":"9508_CR10","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1007\/s00405-022-07367-x","volume":"279","author":"HFE Van der Toom","year":"2022","unstructured":"Van der Toom HFE, van der Schroeff MP, Metselaar M, van Linge A, Vroegop JL, Pauw RJ (2022) A retrospective analysis of hearing after cholesteatoma surgery: the bony obliteration tympanoplasty versus Canal wall up and Canal wall down without mastoid obliteration. Eur Arch Otorhinolaryngol 279(11):5181\u20135189","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"7","key":"9508_CR11","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/MAO.0000000000003150","volume":"42","author":"MC Eggink","year":"2021","unstructured":"Eggink MC, de Wolf MJF, Ebbens FA, Dikkers FG, van Spronsen E (2021) Evaluation of Long-term cholesteatoma recidivism: using the JOS, EAONO-JOS, and STAMCO cholesteatoma staging systems. Otol Neurotol 42(7):1031\u20131038","journal-title":"Otol Neurotol"},{"issue":"12","key":"9508_CR12","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1007\/s00405-022-07400-z","volume":"279","author":"X Wang","year":"2022","unstructured":"Wang X, Guo J, Liu W et al (2022) Comparison of the EAONO\/JOS, STAMCO and chole cholesteatoma staging systems in the prognostic evaluation of acquired middle ear cholesteatoma in children. Eur Arch Otorhinolaryngol 279(12):5583\u20135590","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"11","key":"9508_CR13","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1007\/s00405-023-07996-w","volume":"280","author":"B Renner","year":"2023","unstructured":"Renner B, Vasconcelos Craveiro A, Balk M et al (2023) EAONO\/JOS classification for acquired cholesteatoma: evaluating the impact of the number of affected sites on treatment and outcomes. Eur Arch Otorhinolaryngol 280(11):4827\u20134834","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"9508_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.5152\/iao.2020.7598","volume":"16","author":"FN Ard\u0131\u00e7","year":"2020","unstructured":"Ard\u0131\u00e7 FN, Mengi E, T\u00fcmkaya F, Kara CO, Bir F (2020) Correlation between surgical outcome and stage of acquired middle ear cholesteatoma: revalidation of the EAONO\/JOS staging system. J Int Adv Otol 16(1):34\u201339","journal-title":"J Int Adv Otol"},{"issue":"1","key":"9508_CR15","doi-asserted-by":"publisher","first-page":"17945","DOI":"10.1038\/s41598-023-44901-1","volume":"13","author":"M Fieux","year":"2023","unstructured":"Fieux M, Tournegros R, Hermann R, Tringali S (2023) Allograft bone vs. bioactive glass in rehabilitation of Canal wall-down surgery. Sci Rep 13(1):17945","journal-title":"Sci Rep"},{"issue":"4","key":"9508_CR16","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1002\/oto2.96","volume":"7","author":"VJ Kroon","year":"2023","unstructured":"Kroon VJ, Mes SW, Borggreven PA, van de Langenberg R, Colnot DR, Quak JJ (2023) Efficacy of S53P4 bioactive glass for the secondary obliteration of chronically discharging radical cavities. OTO Open 7(4):e96","journal-title":"OTO Open"},{"issue":"6","key":"9508_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/00129492-200111000-00004","volume":"22","author":"BD Leatherman","year":"2001","unstructured":"Leatherman BD, Dornhoffer JL, Fan CY, Mukunyadzi P (2001) Demineralized bone matrix as an alternative for mastoid obliteration and posterior Canal wall reconstruction: results in an animal model. Otol Neurotol 22(6):731\u2013736","journal-title":"Otol Neurotol"},{"issue":"6","key":"9508_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1017\/S0022215121001195","volume":"135","author":"AK Mishra","year":"2021","unstructured":"Mishra AK, Mallick A, Galagali JR, Gupta A, Sethi A, Ghotra A (2021) Mastoid cavity obliteration using bone p\u00e2t\u00e9 versus bioactive glass granules in the management of chronic otitis media (squamous disease): a prospective comparative study. J Laryngol Otol 135(6):492\u2013500","journal-title":"J Laryngol Otol"},{"issue":"6","key":"9508_CR19","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1097\/MAO.0b013e3182a446da","volume":"35","author":"PC Walker","year":"2014","unstructured":"Walker PC, Mowry SE, Hansen MR, Gantz BJ (2014) Long-term results of Canal wall reconstruction tympanomastoidectomy. Otol Neurotol 35(6):954\u2013960","journal-title":"Otol Neurotol"},{"issue":"6","key":"9508_CR20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/MAO.0b013e3181b23698","volume":"30","author":"N Yanagihara","year":"2009","unstructured":"Yanagihara N, Komori M, Hinohira Y (2009) Total mastoid obliteration in staged canal-up tympanoplasty for cholesteatoma facilitates tympanic aeration. Otol Neurotol 30(6):766\u2013770","journal-title":"Otol Neurotol"},{"issue":"4","key":"9508_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/lary.27588","volume":"129","author":"CA Hellingman","year":"2019","unstructured":"Hellingman CA, Geerse S, de Wolf MJF, Ebbens FA, van Spronsen E (2019) Canal wall up surgery with mastoid and epitympanic obliteration in acquired cholesteatoma. Laryngoscope 129(4):981\u2013985","journal-title":"Laryngoscope"},{"issue":"7","key":"9508_CR22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1080\/00016489.2017.1279346","volume":"137","author":"PD De Veij Mestdagh","year":"2017","unstructured":"De Veij Mestdagh PD, Colnot DR, Borggreven PA, Orelio CC, Quak JJ (2017) Mastoid obliteration with S53P4 bioactive glass in cholesteatoma surgery. Acta Otolaryngol 137(7):690\u2013694","journal-title":"Acta Otolaryngol"},{"issue":"10","key":"9508_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/MAO.0000000000003685","volume":"43","author":"VJ Kroon","year":"2022","unstructured":"Kroon VJ, Mes SW, Borggreven PA, van de Langenberg R, Colnot DR, Quak JJ (2022) Mastoid obliteration using S53P4 bioactive glass in cholesteatoma surgery: A 10-Year Single-Center experience in 173 adult patients with Long-Term magnetic resonance imaging controlled Follow-up. Otol Neurotol 43(10):1181\u20131188","journal-title":"Otol Neurotol"},{"issue":"1","key":"9508_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1034\/j.1600-0501.2002.130106.x","volume":"13","author":"I Allan","year":"2002","unstructured":"Allan I, Newman H, Wilson M (2002) Particulate bioglass reduces the viability of bacterial biofilms formed on its surface in an in vitro model. Clin Oral Implants Res 13(1):53\u201358","journal-title":"Clin Oral Implants Res"},{"issue":"1","key":"9508_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10856-008-3564-5","volume":"20","author":"S Hu","year":"2009","unstructured":"Hu S, Chang J, Liu M, Ning C (2009) Study on antibacterial effect of 45S5 bioglass. J Mater Sci Mater Med 20(1):281\u2013286","journal-title":"J Mater Sci Mater Med"},{"issue":"7","key":"9508_CR26","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3174\/ajnr.A7116","volume":"42","author":"AL Fourez","year":"2021","unstructured":"Fourez AL, Akkari M, Gascou G et al (2021) Optimal duration of MRI Follow-up to safely identify middle ear residual cholesteatoma. AJNR Am J Neuroradiol 42(7):1313\u20131319","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"9508_CR27","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1097\/MAO.0000000000003348","volume":"43","author":"HFE Van der Toom","year":"2022","unstructured":"Van der Toom HFE, van Dinther JJS, Zarowski A et al (2022) Radiological Follow-up after the bony obliteration tympanoplasty in detecting residual cholesteatoma: towards an optimal postoperative MR imaging protocol. Otol Neurotol 43(1):e79\u2013e87","journal-title":"Otol Neurotol"},{"issue":"6","key":"9508_CR28","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1080\/00016489.2022.2094464","volume":"142","author":"E Covelli","year":"2022","unstructured":"Covelli E, Margani V, Filippi C et al (2022) Proposal of a magnetic resonance imaging follow-up protocol after cholesteatoma surgery: a prospective study. Acta Otolaryngol 142(6):484\u2013490","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"9508_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.14639\/0392-100X-2237","volume":"39","author":"R Pareschi","year":"2019","unstructured":"Pareschi R, Lepera D, Nucci R (2019) Canal wall down approach for tympano-mastoid cholesteatoma: long-term results and prognostic factors. Acta Otorhinolaryngol Ital 39(2):122\u2013129","journal-title":"Acta Otorhinolaryngol Ital"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09508-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-025-09508-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09508-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T20:18:34Z","timestamp":1762892314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-025-09508-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["9508"],"URL":"https:\/\/doi.org\/10.1007\/s00405-025-09508-4","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"French ENT ethics committee, Paris, France. Principal investigator: Rapha\u00eble Quatre. IRB approval: 2024-11-044-RQ.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The authors did not receive support from any organization for the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}